GSK a “great believer” in single-use technologies

posted by Phill Allen

February, 19th, 2015

Company News Pharmaceutical Industry News

GSK a “great believer” in single-use technologies
The role of single-use technologies in vaccine development will continue to evolve over the next decade, according to Xavier Derouck of GlaxoSmithKline.
GSK is a “great believer” in single-use systems, Mr Derouck told delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
To ensure single-use technologies are “used to produce vaccines without any risk” to patients, robust risk mitigation strategies needed to be implemented across all rungs of the supply chain, he added.
As such, Mr Derouck forecasted that over the next five to ten years single-use systems would continue moving towards:

  • Compliance
  • Affordability
  • Reliability
  • Process orientated
  • Sustainability

Mr Derouck is GSK’s global senior sourcing manager for single-use technology.

TAGS: GlaxoSmithKline, Single-use,



Phill Allen

Managing Director

An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.

IoTroducing Smart Devices and the Internet of Things
Pharmaceutical Industry News

IoTroducing Smart Devices and the Internet of Things

The Internet of Things (known to its friends as IoT) is the collective name given to devices which contain computer […]

Jun 26th, 2022